Featured Research

from universities, journals, and other organizations

New septic shock biomarker test could boost better interventions

Date:
March 26, 2014
Source:
Cincinnati Children's Hospital Medical Center
Summary:
Septic shock is a severe systemic infection and major cause of death for old and young alike. Unfortunately, researchers say testing new drugs to stop the infection is confounded because clinical trials include patients who are either too sick to be saved by experimental therapies or not sick enough to warrant the treatments. A new study reports a new blood test helps solve the dilemma by identifying low-risk and high-risk patients.

Septic shock is a severe systemic infection and major cause of death for the old and young alike. Unfortunately, researchers say testing new drug regimens to stop the infection is confounded because clinical trials include patients who are either too sick to be saved by experimental therapies or not sick enough to warrant the treatments.

In a study published in the April edition of Critical Care Medicine, researchers at Cincinnati Children's Hospital Medical Center and the University of Cincinnati report a new blood test that helps solve the dilemma by identifying low-risk and high-risk patients. Based on genome-wide studies of septic shock patients, the tool measures five protein biomarkers in the blood that are combined to accurately estimate the risk of mortality and determine which patients should receive experimental therapeutic intervention.

The study involved 882 adults in intensive care units in medical centers located in the United States, Finland and Canada. The new study follows one published earlier this year by the same research group that developed a similar test for children. The new study included three different groups of patients to develop, test and retest the tool. This helps to make sure it works in different patient mixes -- often a limiting factor in large clinical trials.

"Substantial resources are invested in trying to find new treatments for septic shock, but the vast majority of them fail when they get to clinical trials," explains Hector Wong, MD, a lead investigator and director of Critical Care Medicine at Cincinnati Children's. "There are many reasons for this, but a consistent one is that the baseline mortality risk varies widely in septic shock patients, which muddies the water."

Helping lead the study was Wong's collaborator, Christopher Lindsell, PhD, Professor of Emergency Medicine and Associate Dean for Clinical Research at the University of Cincinnati College of Medicine.

Septic shock can cause inflammation and damage to critical organs. Organ damage is a key driver of the infection's deadly nature. The authors say a significant part of the challenge in determining who is at greatest risk of death is the complex medical variation among patients with septic shock -- who differ in age, underlying medical conditions and general overall health.

Researchers selected the biomarkers used in the stratification tool because of the clear links they have to a person's infection and inflammation. As well as biomarkers, the researchers included measurements of patient age, lactate levels, and the number of chronic diseases patients had. They then used a mathematical model to combine the information into a single tool that separates high- and low-risk patients.

The authors report that in general the tool accurately determined that patients who tested positive had less than a 50 percent chance of surviving, but patients who tested negative had more than a 90 percent chance of surviving. More detailed analyses lets the authors identify patients with a more than a 98 percent chance of surviving, and those with more than 75 percent chance of dying.

When the researchers tested the tool repeatedly in different groups of patients, it continued to perform well. It also performed better than what is already available, the APACHE II/III (Acute Physiology and Chronic Health Evaluation) testing. The authors say this is because APACHE II/III does not use blood tests and relies more heavily on measurements with considerable variation, such as blood pressure.

One important finding is that three of the biomarkers helpful in stratifying risk for adults were the same as those used for stratifying children. The researchers say having the same three biomarkers verified in both groups mean that, in addition to identifying those patients unlikely to survive, the biomarkers consistently point to the same underlying problems caused by sepsis, providing potential targets for treatment. Not only can the tool help identify which patients should be included in clinical trials, it also points to specific treatments that should be tested.


Story Source:

The above story is based on materials provided by Cincinnati Children's Hospital Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hector R. Wong, Christopher J. Lindsell, Ville Pettilδ, Nuala J. Meyer, Simone A. Thair, Sari Karlsson, James A. Russell, Christopher D. Fjell, John H. Boyd, Esko Ruokonen, Michael G. S. Shashaty, Jason D. Christie, Kimberly W. Hart, Patrick Lahni, Keith R. Walley. A Multibiomarker-Based Outcome Risk Stratification Model for Adult Septic Shock*. Critical Care Medicine, 2014; 42 (4): 781 DOI: 10.1097/CCM.0000000000000106

Cite This Page:

Cincinnati Children's Hospital Medical Center. "New septic shock biomarker test could boost better interventions." ScienceDaily. ScienceDaily, 26 March 2014. <www.sciencedaily.com/releases/2014/03/140326092610.htm>.
Cincinnati Children's Hospital Medical Center. (2014, March 26). New septic shock biomarker test could boost better interventions. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2014/03/140326092610.htm
Cincinnati Children's Hospital Medical Center. "New septic shock biomarker test could boost better interventions." ScienceDaily. www.sciencedaily.com/releases/2014/03/140326092610.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) — The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
'Cadaver Dog' Sniffs out Human Remains

'Cadaver Dog' Sniffs out Human Remains

AP (Oct. 21, 2014) — Where's a body buried? Buster's nose can often tell you. He's a cadaver dog, specially trained to find human remains and increasingly being used by law enforcement and accepted in courts. These dogs are helping solve even decades-old mysteries. (Oct. 21) Video provided by AP
Powered by NewsLook.com
How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) — The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
How Detroit's Money Woes Led To U.N.-Condemned Water Cutoffs

How Detroit's Money Woes Led To U.N.-Condemned Water Cutoffs

Newsy (Oct. 20, 2014) — The United Nations says water is a human right, but should it be free? Detroit has cut off water to residents who can't pay, and the U.N. isn't happy. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins